IL-8 and Its Role in Chronic Liver Disease
Author Information
Author(s): Henning W. Zimmermann, Sebastian Seidler, Nikolaus Gassler, Jacob Nattermann, Tom Luedde, Christian Trautwein, Frank Tacke
Primary Institution: University Hospital, Aachen, Germany
Hypothesis
Is the IL-8 pathway activated in patients with chronic liver disease?
Conclusion
IL-8 is strongly activated in chronic liver disease, likely contributing to hepatic inflammation and macrophage recruitment.
Supporting Evidence
- IL-8 serum levels were significantly increased in chronic liver disease patients compared to healthy controls.
- Patients with end-stage cirrhosis exhibited the highest IL-8 serum concentrations.
- IL-8 correlated with liver function and inflammatory cytokines.
Takeaway
This study found that a substance called IL-8 is higher in people with liver disease, which might help attract certain immune cells to the liver.
Methodology
Serum IL-8 levels were measured in chronic liver disease patients and healthy controls, alongside gene expression analysis from liver samples.
Participant Demographics
200 patients with chronic liver disease, 141 healthy controls; median age 53 years, 124 males and 76 females.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website